ArticleOncoTargets and therapy2017

Sequential treatment of tyrosine kinase inhibitor and platinum-based doublet chemotherapy on EGFR mutant non-small cell lung cancer: a meta-analysis of randomized controlled clinical trials.

Lifen Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.